Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
Geletneky
Karsten
K
Department of Neurological Surgery, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. K.Geletneky@Dkfz-Heidelberg.de
Kiprianova
Irina
I
Ayache
Ali
A
Koch
Regina
R
Herrero Y Calle
Marta
M
Deleu
Laurent
L
Sommer
Clemens
C
Thomas
Nadja
N
Rommelaere
Jean
J
Schlehofer
Jörg R
JR
D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D001921:Brain / Q000473:pathology / Q000821:virology; D001932:Brain Neoplasms / Q000473:pathology / Q000628:therapy*; D004279:DNA, Viral / Q000302:isolation & purification; D004195:Disease Models, Animal; D005910:Glioma / Q000473:pathology / Q000628:therapy*; D052661:H-1 parvovirus; D006801:Humans; D008279:Magnetic Resonance Imaging; D050130:Oncolytic Virotherapy / Q000379:methods*; D016133:Polymerase Chain Reaction; D051381:Rats; D023041:Xenograft Model Antitumor Assays
D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D004279:DNA, Viral